Latest NewsNewsTFT News

WHO: PH completes requirements for AstraZeneca vaccines

The Philipine government has submitted all the requirements needed for the AstraZeneca vaccines, which will be supplied by the COVAX facility of the World Health Organization.

The COVAX Facility is an initiative that aims to provide its member-countries an equitable access to COVID-19 vaccines.

“I also want to update you that the Philippines has met all the requirements necessary for accessing the AstraZeneca vaccines,” WHO Country Representative Rabindra Abeyasinghe said during a briefing with the Department of Health.

The WHO official confirmed around 5.5 million to 9.2 million doses of AstraZeneca’s vaccine have been set aside for the country.

The government expects the delivery of AstraZeneca from WHO within the first quarter of the year.

“What we are now looking at is accelerating delivery of those AstraZeneca vaccines, at least a part of that shipment to the Philippines,” Abeyasinghe added.

“I understand that the Department of Health has supplied all the letters necessary to the COVAX initiative to access the early rollout of those AstraZeneca vaccines,” the WHO official said.

He also said that AstraZeneca did no longer demand for more documents before their vaccine delivery, unlike Pfizer.

“We are optimistic that before the end of this week, we will hear from the COVAX initiative on likely delivery dates for AstraZeneca vaccines to the Philippines,” he said.

AstraZeneca will use its facility in South Korea dedicated to exclusively manufacture the COVAX Facility’s vaccine requirements.

“And what is earmarked for the Philippines will be coming from South Korea. So, we still remain optimistic that we will receive the AstraZeneca vaccines within the timeframes that we were talking about,” he said. (TDT)

Staff Report

The Filipino Times is the chronicler of stories for, of and by Filipinos all over the world, reaching more than 236 countries in readership. Any interesting story to share? Email us at [email protected]

Related Articles

Back to top button
Close